CRNX vs HBAN · rev $7.7M vs P/E 13, rev $1.56B
Crinetics Pharmaceuticals Inc (CRNX) versus Huntington Bancshares Incorporated (HBAN) — a side-by-side from cached financials, not a winner call.
Crinetics Pharmaceuticals Inc (CRNX) is a biotechnology company listed on US.
Huntington Bancshares Incorporated (HBAN) is a banks - regional company listed on US.
Latest reported CRNX revenue for 2025-12-31 was $7.7M. Net income was -$465.3M. CRNX currently screens at market cap $2.76B.
Latest reported HBAN revenue for 2025-12-31 was $1.56B. Net income was $2.21B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
CRNX currently screens at market cap $2.76B. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
Not investment advice. Open the CRNX and HBAN stock pages for the full models.
Not investment advice.